From January 1, 2024 to April 1, 2024, the company has repurchased 6,500,000 shares, representing 0.46% for CNY 39.94 million. With this, the company has completed the repurchase of 15,500,000 shares, representing 1.11% for CNY 100.01 million under the buyback announced on December 8, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.72 CNY | +1.05% | -2.18% | +1.36% |
May. 27 | Renhe Pharmacy Co.,Ltd Approves Cash Dividend for 2023 | CI |
May. 23 | Renhe Pharmacy Gets Nod to Market Oseltamivir Phosphate Capsules | MT |
1st Jan change | Capi. | |
---|---|---|
+1.36% | 1.27B | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- 000650 Stock
- News Renhe Pharmacy Co.,Ltd
- Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023.